SUCLG2 identified as both a determinator of CSF Abeta1-42 levels and an attenuator of cognitive decline in Alzheimer's disease

A. Ramirez, W.M. van der Flier, C. Herold, D. Ramonet, S. Heilmann, P. Lewczuk, J. Popp, A. Lacour, D. Drichel, E. Louwersheimer, M.P. Kummer, C. Cruchaga, P. Hoffmann, C.E. Teunissen, H. Holstege, J. Kornhuber, O. Peters, A.C. Naj, V. Chouraki, C. BellenguezA. Gerrish, R. Heun, L. Frolich, M. Hull, L. Buscemi, S. Herms, H. Kolsch, P. Scheltens, M.M. Breteler, E. Ruther, J. Wiltfang, A. Goate, F. Jessen, W. Maier, M.T. Heneka, T. Becker, M. M. Nothen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)6644-6658
JournalHuman Molecular Genetics
Volume23
Issue number24
DOIs
Publication statusPublished - 2014

Cite this